‹ ›
MYP_051703
← PREVIOUS NEXT → BACK
Basic Information
SV-465
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Standard
31 amino acids
C160H256N44O49
Standard
Sequence
LNLADATNFLQDSKAELEKARKILSEVGRWY
Physicochemical Analysis
3580.01 Da
6.28
-0.23
-0.45
-0.0075
-0.51
0.79
-0.11
45.61
97.74
0.0968
6990.00
6990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1550.66
-13.66
54.0
49.0
123.0
253.0
4.0
33.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0031089 VERIFIED: YES
Provenance & Taxonomy
Murine respirovirus (Sendai virus) [Virus]
Virus-derived peptide
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Fusion inhibitor Hemolytic
Sendai virus (Fusion); RBCs
80 %
Hemolysis
PaperStructure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion. | Ghosh JK, Peisajovich SG, Ovadia M, Shai Y. | J Biol Chem. 1998 | PMID:9765238 PMID9765238 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/9765238/
RECORD: Rec_0183989 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 64.5%, E 0.0%, T 16.1%, C 19.4% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/